Last reviewed · How we verify
NCT06347822
Increasing Access to Evidence-Based Care in Integrated Behavioral Health
NA trial testing Therapy Session in Psychotherapy in 34 participants. Completed in 5 June 2025.
19 May 2025
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 34 |
| Start date | 17 June 2024 |
| Primary completion | 19 May 2025 |
| Estimated completion | 5 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Therapy Session
Conditions studied
- Psychotherapy — all drugs for Psychotherapy →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Psychotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to explore whether a single-session therapy visit may be of interest to patients seeking mental health services in Mayo Clinic's Integrated Behavioral Health program and whether a single-session therapy visit may be helpful in improving mental health. Researchers hope to better understand whether single-session visits could be a helpful option to offer patients in the future.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Implementation of a single session psychotherapy intervention in primary care integrated behavioral health: a single-arm pilot study.
Roche AI, Straub BL, Thomas EBK, Eadeh HM, et al · · 2026 · PMID 42151859 · DOI 10.1186/s12875-026-03361-y
Verify or expand the search:
- PubMed search for NCT06347822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotherapy
Currently open trials in the same condition.
- NCT07147205 — Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine · NA · recruiting
- NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
- NCT06674499 — Development and Evaluation of a Self-Management Model for Cancer Rehabilitation · NA · active not recruiting
- NCT04356924 — Psychological Treatment to Support the Consequences of Cognitive Impairment · NA · recruiting
- NCT05587517 — A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients · Phase 2 · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06347822 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 14 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06347822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing